A similar finding was recently published by Leclerc et al. [6], who showed in a B16F10 melanoma model that anti-NRP-1 mAbs enhanced the migration and cytotoxicity of CD8+ tumor-infiltrating T cells. Here, NRP1 is linked to melanoma.